Module 3 - Strategic case studies in practice

First page Table of contents Previous page 523 Next page Last page

I.

SUMMARY OF NOTIFIED BODY OPINION

763 764

765

767 768

Guideline on the quality requirements for drug-device combinations

EMA/CHMP/QWP/BWP/259165/2019

Page 24/26

Made with FlippingBook Learn more on our blog